The copyright and Pharma: A Risky Bet?

The history of Viagra presents a complex picture for those considering investment. While the initial release generated significant profits, the lapse of its patent opened the floodgates to generic alternatives, dramatically diminishing market share. This presents a particular dilemma for firms banking on related blockbuster products, suggesting tha

read more

Sildenafil and the Pharmaceutical Sector : A Precarious Opportunity?

The legacy of Viagra, and its creator copyright, presents a complex case study for investors. Originally a blockbuster drug, generating billions in revenue , its exclusivity period created a flood of knock-off medications, significantly diminishing its dominance. While specific businesses may attempt to capitalize on similar conditions , the curren

read more